Avanos Medical AVNS Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | |||||
| PM&R | $9.2M+241% | $2.7M+173% | -$3.7M— | —— | |
| Total Specialty Nutrition Systems | $82.6M+2.2% | $80.8M+1.0% | $80M— | —— | |
| Other segment items by Business | |||||
| PM&R | -$100K— | —— | $0— | —— | |
| Change in segments by Business | |||||
| Total Pain Management and Recovery | $128M— | —— | —— | —— | |
| Total Specialty Nutrition Systems | $327.6M— | —— | —— | —— | |
| General expenses by Business | |||||
| PM&R | -$48.5M-27.6% | -$38M+2.1% | -$38.8M— | —— | |
| Total Specialty Nutrition Systems | -$69.5M-27.3% | -$54.6M-6.0% | -$51.5M— | —— | |
| Currency translation adjustment by Business | |||||
| PM&R | $2.6M— | —— | —— | —— | |
| Total Specialty Nutrition Systems | $0— | —— | —— | —— | |
| Advertising, promotion and selling expenses by Business | |||||
| PM&R | -$62.3M+20.1% | -$78M-3.7% | -$75.2M— | —— | |
| Total Specialty Nutrition Systems | -$53.6M+20.0% | -$67M-11.5% | -$60.1M— | —— | |
| Cost of goods sold by Business | |||||
| PM&R | -$85.7M-1.7% | -$84.3M-2.8% | -$82M— | —— | |
| Total Specialty Nutrition Systems | -$165.1M-21.8% | -$135.6M-8.1% | -$125.4M— | —— | |
| Depreciation and amortization expense by Business | |||||
| PM&R | -$14.7M-9.7% | -$13.4M-0.8% | -$13.3M— | —— | |
| Total Specialty Nutrition Systems | -$20.4M-24.4% | -$16.4M+7.9% | -$17.8M— | —— | |
| Distribution by Business | |||||
| PM&R | -$12.6M-20.0% | -$10.5M+11.8% | -$11.9M— | —— | |
| Total Specialty Nutrition Systems | -$24.9M-0.8% | -$24.7M-11.3% | -$22.2M— | —— | |
| Research and development expenses by Business | |||||
| PM&R | -$4.8M+34.2% | -$7.3M+25.5% | -$9.8M— | —— | |
| Total Specialty Nutrition Systems | -$16.7M+3.5% | -$17.3M-18.5% | -$14.6M— | —— | |
| Goodwill by Business | |||||
| PM&R | $288.3M— | —— | —— | —— | |
| Total Specialty Nutrition Systems | $1.34B— | —— | —— | —— | |
| Net Sales by Product | |||||
| Enteral feeding | $314.7M+8.6% | $289.7M+2.3% | $283.3M— | —— | |
| Neonate solutions | $118.2M+10.8% | $106.7M+20.8% | $88.3M— | —— | |
| Radiofrequency ablation | $139M+10.1% | $126.2M+14.9% | $109.8M— | —— | |
| Surgical pain and recovery | $98.8M-8.5% | $108M-8.1% | $117.5M-26.6% | $160.1M-1.6% | |
| Percentage of total net sales by Product | |||||
| Distribution Rebates | 53%-1.0pp | 54%+5.0pp | 49%-3.0pp | 52%-5.0pp | |
| Incentives | 29%+1.0pp | 28%0.0pp | 28%-4.0pp | 32%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
